Clinical Features of Recurrent Embolization in Acute Cardioembolic Stroke
Stroke 24:1681-1685, Yasaka,M.,et al, 1993
Racial Variations in the Rates of Carotid Angiography and Endarterectomy in Patients with Stroke and TIA
Arch Int Med 153:2781-2786, Oddone,E.Z.,et al, 1993
Wallenberg's Lateral Medullary Syndrome
Arch Neurol 50:609-614, Sacco,R.L.,et al, 1993
Transient Ischemic Cerebral Lesions During Induction Chemotherapy for Acute Lymphoblastic Leukemia
J Pediatr 123:718-724, Pihko,H.,et al, 1993
Transient Ischemic Attacks in Younger and Older Patients:A Comparative Study of 798 Patients in South Africa
Stroke 24:947-953, Giovannoni,G.&Fritz,V.U., 1993
Idiopathic Granulomatous Angiitis of the Central Nervous System
Arch Neurol 50:925-930, Vollmer,T.L.,et al, 1993
Effect of Low-Intensity Warfarin Anticoag on Level of Activity of Hemostatic System in Pts with Atrial Fib
Stroke 24:1360-1365, Kistler,J.P.,et al, 1993
Computed Tomographic Evidence of an Extensive Thrombosis and Infarction of the Deep Venous System
Stroke 24:744-746, Ur-Rahman,N.&Al-Tahan,A.R., 1993
Alternating Hemiplegia of Childhood:A Study of 10 Pts & Results of Flunarizine Treatment
Neurol 43:36-41, Silver,K.&Andermann,F., 1993
Safety of Anticoagulation After Hemorrhagic Infarction
Neurol 43:1298-1303, Pessin,M.S.,et al, 1993
Sneedon's Syndrome:Diagnosis by Skin Biopsy and MRI in 17 Patients
Stroke 24:685-690, Stockhammer,G.,et al, 1993
The Management of Acute Visual Failure
JNNP 56:234-240, Wray,S.H., 1993
Anterior Inferior Cerebellar Artery Territory Infarcts, Mechanisms and Clinical Features
Arch Neurol 50:154-161, Amarenco,P.,et al, 1993
Antithrombotic Therapy in Acute Ischaemic Stroke:An Overviews of the Completed Randomized Trials
JNNP 56:17-25, Sandercock,P.A.G.,et al, 1993
Delayed Peripartum Vasculopathy:Cerebral Eclampsia Revisited
Ann Neurol 33:222-225, Raps,E.C.,et al, 1993
The Efficacy & Safety of Ticlopidine & Aspirin in Non-Whites:Subgroup from Ticlopidine Aspirin Stroke Study
Neurol 43:27-31, Weisberg,L.A., 1993
Ophthalmoplegia, Hemiparesis and Cheiro-Oral Syndrome in Basilar Artery Migraine
Eur Neurol 33:185-187, Yasuda,Y.,et al, 1993
Predictors of Thromboembolism in Atrial Fibrillation:I. Clinical Features of patients at Risk
The Stroke Prevention in A Fib Investigators, Ann Int Med 116:1-51992., , 1992
Subarachnoid Haemorrhage
Lancet 339:653-655, Van Gijn,J., 1992
Prevention of Stroke with Ticlopidine:Who Benefits Most?
Neurol 42:111-115, Grotta,J.C.,et al, 1992
Cerebral Hemorrhage with Biopsy-Proved Amyloid Angiopathy
Arch Neurol 49:51-58, Yong,W.H.,et al, 1992
Cardiogenic Embolism to the Brain
Lancet 339:589-594, Hart,R.G., 1992
Anticoagulant Treatment as a Risk Factor for Primary Intracerebral Hemorrhage
JNNP 55:1121-1124, Fogelholm,R.,et al, 1992
Cost Effectiveness of Primary Stroke Prevention in Atrial Fibrillation
BMJ 305:1457-1460, 14451992., Gustafsson,C.,et al, 1992
Warfarin in the Prevention of Stroke Associated with Nonrheumatic Atrial Fibrillation
NEJM 327:1406-1412, 14511992., Ezekowitz,M.D.,et al, 1992
Carotid Endarterectomy:Recommendations for Manag of Transient Ischaemic Attack and Ischaemic Stroke
BMJ 305:1071-1074, Brown,M.M.,et al, 1992
Ticlopidine vs Aspirin for Prevention of Recurrent Stroke, Analysis of Pts with Stroke from Ticlopidine Aspirin Study
Stroke 23:1723-1727, Harbison,J.W., 1992
Effects of Low-to-High Doses of Aspirin on Platelet Aggregab & Metabol of Thromboxane A2 & Prostacyclin
Stroke 23:1400-1403, Tohgi,H.,et al, 1992
Low-Dose Aspirin and Stroke"It Ain't Necessarily So"
Stroke 23:1395-1399, Dyken,M.L.,et al, 1992
Endovascular Treatment of Vertebral Arteriovenous Fistula
Radiology 183:361-367, Beaujeux,R.L.,et al, 1992
Lyme Disease Associated with Fibromyalgia
Ann Int Med 117:281-285, Dinerman,H.&Steere,A.C., 1992
Neurological Complications Following Liver Transplantation
Ann Neurol 31:644-649, Stein,D.P.,et al, 1992
Secondary Prevention of Stroke
Lancet 339:724-727, Warlow,C., 1992
Cysticercosis and Cerebrovascular Disease:A Review
JNNP 55:252-254, DelBrutto,O.H., 1992
Cerebellar Infarction in the Young
Stroke 23:763-766, Rosman,N.P.,et al, 1992
Thromboendartectomy of the Symptomatic Occluded Internal Carotid Artery
J Neurosurg 76:752-758, McCormick,P.W.,et al, 1992
Treatment of Cerebellar Infarction by Decompressive Suboccipital Craniectomy
Stroke 23:957-961, 9371992., Chen,H-J.,et al, 1992
Role of Ticlopidine for Prevention of Stroke
Stroke 23:912-916, Albers,G.W., 1992
European Stroke Prevention Study:Effectiveness of Antiplatelet Therapy in Diabetics in Secondary Prevent of Stroke
Stroke 23:851-854, Sivenius,J.,et al, 1992
Safety & Efficacy of Intravenous Tissue Plasminogen Activator & Heparin in Acute Middle Cerebral Artery Stroke
Stroke 23:646-652, vonKummer,R.&Hacke,W., 1992
Ticlopidine for Prevention of Stroke
The Medical Letter, 34:65-661992., , 1992
A Critical Appraisal of Ticlopidine, A New Antiplat Agent, Effectiveness & Clin Indic for Prophylaxis
Arch Int Med 152:1376-1380, Haynes,R.B.,et al, 1992
Cerebral Venous Thrombosis
Bousser, M-G & Barnett, H. J. M. , in Stroke, Pathophysiol, Diag & Manage, 2nd Ed, Churchhill Living, tone, NY, Ch 19,, 1992
Antithrombotic Therapy in Cerebrovascular Disease
Ann Int Med 115:885-895, Rothrock,J.F.&Hart,R.G., 1991
Stroke Prevention in Nonvalvular Atrial Fibrillation:A Review of Prospective Randomized Trials
Ann Neurol 30:511-518, Albers,G.W.,et al, 1991
Influence of Low-Intensity Warfarin Treatment of Patients'Perceptions of Quality of Life
Editorial, Arch Int Med 151:1921-1922, 1944-1949991., , 1991
Stroke Prevention in Nonvalvular Atrial Fibrillation
Ann Int Med 115:727-736, Albers,G.W.,et al, 1991
Physicians'Attitudes Toward Anticoag & Antiplat Agents for Stroke Prevent in Elderly Pts with Atrial Fib
Arch Int Med 151:1950-1953, 19221991., Kutner,M.,et al, 1991
A Comparison of Two Doses of Aspirin (30 mg vs. 283 mg/day) in Pats. After a TIA or Minor Ischemic Stroke
Dutch TIA Trial Study Group, NEJM 325:1261-1266, 1303991., , 1991
Swedish Aspirin Low-Dose Trial (SALT) of 75 mg Aspirin as Secondary Prophylaxis After Cerebrovascular Ischaemic Events
The SALT Coll Group, Lancet 338:1345-13491991., , 1991